MeTC7
MeTC7 is a small molecule antagonist of the vitamin D receptor (VDR) that demonstrates antitumor properties by suppressing PD-L1. It has shown efficacy in inhibiting tumor growth in both xenograft and transgenic mouse models, making it a valuable tool for cancer immunotherapy and oncology research.
Product Specifications
CAS Number
1817841-22-7
Product Name Alternative
MeTC 7, MeTC7, Miransertib dimesylate, Miransertib mesylate, VD
Field of Research
Metabolism Research
Purity
99.54% (May vary between batches)
Solubility
DMSO:20 mg/mL (32.33 mM) ;10% DMSO+90% Corn Oil:1 mg/mL (1.62 mM)
Smiles
O=C1N2C34[C@@] ([C@]5 (C) C (N2C (=O) N1C) (C=C3) C[C@@H] (OC (CBr) =O) CC5) (CC[C@@]6 (C) [C@]4 (CC[C@@]6 ([C@@H] (CCCC (C) C) C) [H]) [H]) [H]
Molecular Formula
C32H48BrN3O4
Molecular Weight
618.65
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog